Drug Type Antibody |
Synonyms |
Mechanism Andes hantavirus glycoprotein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hantavirus Infections | Preclinical | US | 14 Jun 2023 | |
Hantavirus Infections | Preclinical | US | 14 Jun 2023 | |
Hantavirus Infections | Preclinical | US | 14 Jun 2023 |